Glenmark to launch Sodium Phosphates Injection USP single-dose vials in april 2026
Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million annual market sales
Author
GSK survey flags Shingles impact and prevention gaps among adults with chronic conditions in India
Findings released ahead of Shingles Action Week show low awareness and limited doctor-patient discussions on risk and vaccination
Bayer secures India approval for expanded use of Nubeqa
Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data with Indian participation
Eli Lilly India launches obesity awareness campaign
Initiative positions obesity as a chronic disease and highlights role of doctors in evidence-based care
Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating tablets
Company secures final approval for ANDA across four strengths; cumulative USFDA ANDA approvals reach 235
MSD appoints Brecht Vanneste as MD for India
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based in Mumbai
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
B&R India hosts Innovations Day 2026 to showcase smart manufacturing solutions
Event highlights intelligent automation, industry collaboration, and next-generation motion control technologies
Biocon receives US FDA approval for Liraglutide Injection gSaxenda
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the United States
Lupin receives US FDA approval for Brivaracetam Oral Solution 10 mg/mL
Company initiates US launch following ANDA approval for bioequivalent to Briviact